发明名称 |
Induction of mucosal tolerance to antigens |
摘要 |
Induction of tolerance to antigens by mucosal, preferably oral, delivery of the antigen in combination with an immunomodulating compound producing micro-organism is disclosed. More specifically, Foxp3+ and/or IL-10 and/or TGF-β producing regulatory T-cells are induced which are capable of suppressing undesired immune responses toward an antigen. The antigen is preferably delivered orally in combination with an immunosuppressing cytokine secreting micro-organism. |
申请公布号 |
US8748126(B2) |
申请公布日期 |
2014.06.10 |
申请号 |
US20060094384 |
申请日期 |
2006.11.29 |
申请人 |
Actogenix N.V. |
发明人 |
Rottiers Pieter;Snoeck Veerle |
分类号 |
C12P21/06 |
主分类号 |
C12P21/06 |
代理机构 |
|
代理人 |
|
主权项 |
1. A composition for treating celiac disease comprising an IL-10 secreting Lactococcus lactis in combination with gliadin, or in combination with a gliadin peptide which binds HLA-DQ2 and/or HLA-DQ8.
|
地址 |
Zwijnaarde BE |